诺普信：11月24日召开董事会会议

Core Viewpoint - Noposion (SZ 002215) announced a temporary board meeting on November 24, 2025, to discuss the stock issuance plan for 2025 [1] Group 1: Financial Performance - For the first half of 2025, Noposion's revenue composition is as follows: 49.42% from supply chain business, 40.45% from pesticide formulation business, and 10.13% from the Tiantian Circle business [1] - As of the report, Noposion's market capitalization is 11.6 billion yuan [1] Group 2: Regulatory Issues - The company is under investigation by the China Securities Regulatory Commission (CSRC) due to a significant loss exceeding 100 million yuan shortly after its IPO, with its main customer reducing purchases for self-use [1]